The FDA could soon authorize emergency use of blood plasma collected from people who have recovered from COVID-19 to treat newly sickened patients, according to sources. The decision could be issued as early as next week, the sources said.
FDA may authorize convalescent plasma for COVID-19
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.